203 related articles for article (PubMed ID: 28947209)
1. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.
Hata S; Ise K; Azmahani A; Konosu-Fukaya S; McNamara KM; Fujishima F; Shimada K; Mitsuzuka K; Arai Y; Sasano H; Nakamura Y
Life Sci; 2017 Dec; 190():15-20. PubMed ID: 28947209
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
3. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
[TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
5. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
6. Steroid 5alpha reductase mRNA type 1 is differentially regulated by androgens and glucocorticoids in the rat liver.
El-Awady MK; El-Garf W; El-Houssieny L
Endocr J; 2004 Feb; 51(1):37-46. PubMed ID: 15004407
[TBL] [Abstract][Full Text] [Related]
7. Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
Li J; Ding Z; Wang Z; Lu JF; Maity SN; Navone NM; Logothetis CJ; Mills GB; Kim J
PLoS One; 2011; 6(12):e28840. PubMed ID: 22194926
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone increases the risk of bladder cancer in men.
Gil D; Zarzycka M; Dulińska-Litewka J; Ciołczyk-Wierzbicka D; Lekka M; Laidler P
Hum Cell; 2019 Jul; 32(3):379-389. PubMed ID: 31119584
[TBL] [Abstract][Full Text] [Related]
9. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
10. Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes.
McNamara KM; Yoda T; Nurani AM; Shibahara Y; Miki Y; Wang L; Nakamura Y; Suzuki K; Yang Y; Abe E; Hirakawa H; Suzuki T; Nemoto N; Miyashita M; Tamaki K; Ishida T; Brown KA; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2014 Jun; 145(2):281-93. PubMed ID: 24715382
[TBL] [Abstract][Full Text] [Related]
11. Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.
Peng HM; Valentín-Goyco J; Im SC; Han B; Liu J; Qiao J; Auchus RJ
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32716491
[TBL] [Abstract][Full Text] [Related]
12. Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.
McNamara KM; Yoda T; Miki Y; Chanplakorn N; Wongwaisayawan S; Incharoen P; Kongdan Y; Wang L; Takagi K; Mayu T; Nakamura Y; Suzuki T; Nemoto N; Miyashita M; Tamaki K; Ishida T; Ohuchi N; Sasano H
Cancer Sci; 2013 May; 104(5):639-46. PubMed ID: 23373898
[TBL] [Abstract][Full Text] [Related]
13. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.
Suzuki T; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Int J Cancer; 2007 Jan; 120(2):285-91. PubMed ID: 17066438
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
[TBL] [Abstract][Full Text] [Related]
15. Prostate epithelial AR inactivation leads to increased intraprostatic androgen synthesis.
McNamara KM; Nakamura Y; Sasano H; Handelsman DJ; Simanainen U
Prostate; 2013 Feb; 73(3):316-27. PubMed ID: 22976924
[TBL] [Abstract][Full Text] [Related]
16. Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status.
Akahira JI; Suzuki T; Ito K; Darnel AD; Moriya T; Sato S; Yaegashi N; Okamura K; Sasano H
Jpn J Cancer Res; 2001 Sep; 92(9):926-32. PubMed ID: 11572759
[TBL] [Abstract][Full Text] [Related]
17. Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling.
Yang L; Huang W; Bai X; Wang H; Wang X; Xiao H; Li Y
Cell Death Dis; 2023 Jun; 14(6):363. PubMed ID: 37328487
[TBL] [Abstract][Full Text] [Related]
18. Androgens modulate male-derived endothelial cell homeostasis using androgen receptor-dependent and receptor-independent mechanisms.
Torres-Estay V; Carreño DV; Fuenzalida P; Watts A; San Francisco IF; Montecinos VP; Sotomayor PC; Ebos J; Smith GJ; Godoy AS
Angiogenesis; 2017 Feb; 20(1):25-38. PubMed ID: 27679502
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent expression of 5alpha-reductase and androgen receptors mRNA by the canine prostate.
Shidaifat F
Physiol Res; 2009; 58(1):155-158. PubMed ID: 18198998
[TBL] [Abstract][Full Text] [Related]
20. Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol.
Eivers SB; Kinsella BT
Biochim Biophys Acta; 2016 Oct; 1859(10):1333-51. PubMed ID: 27365208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
